Hypothesis to explain poor outcomes in the ALLHAT and V-HeFT trials: decreased expression of heat shock proteins

Hypothesis to explain poor outcomes in the ALLHAT and V-HeFT trials: decreased expression of heat shock proteins

<p>Abstract</p> <p>An explanation for the higher incidence of cardiovascular disease and heart failure in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) with doxazosin and the Vasodilator Heart Failure Trial (V-HeFT) with prazosin might be...

Full description

Bibliographic Details
Main Author: Hooper Philip L
Format: Article
Language:English
Published: BMC 2001-09-01
Series:Current Controlled Trials in Cardiovascular Medicine
Subjects:
α-adrenergic blockers
calcium-channel blockers
congestive heart failure
doxazosin
heat shock proteins
Online Access:http://dx.doi.org/10.1186/cvm-2-6-251

Similar Items

Similar Items